These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 3762520

  • 1. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
    [Abstract] [Full Text] [Related]

  • 3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 4. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 5. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 6. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 7. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 8. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 9. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ, Delen FM.
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M, Waelbroeck M, Christophe J.
    J Recept Res; 1986 Jul; 6(1):47-61. PubMed ID: 3754901
    [Abstract] [Full Text] [Related]

  • 11. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 12. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 13. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ, Jenden DJ.
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [Abstract] [Full Text] [Related]

  • 14. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 15. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD, Vaishnav AA, Mash DC.
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [Abstract] [Full Text] [Related]

  • 16. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 18. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J, Wang SZ, Forray C, el-Fakahany EE.
    Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
    [Abstract] [Full Text] [Related]

  • 19. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 20. Circadian rhythm in muscarinic receptor subtypes in rat forebrain.
    Marquez E, Pavia J, Laukonnen S, Martos F, Gomez A, Rius F, Sanchez de la Cuesta F.
    Chronobiol Int; 1990 Dec; 7(4):277-82. PubMed ID: 2085868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.